Prediction of valproate serum concentrations in adult psychiatric patients using Bayesian model estimations with NPEM2 population pharmacokinetic parameters

Therapeutic Drug Monitoring

Volumn 21, Issue 3, 1999, Pages 351-354

  Puentes, Elizabeth ^a,b   Puzantian, Talia ^c,d,e   Lum, Bert L ^a,b,e,f  

^a Vet Aff Palo Alto Hlth Care Syst ^*  (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f STANFORD CANCER INSTITUTE   (United States)

Author keywords

Bayesian estimation; Pharmacokinetics; Population Pharmacokinetics; Psychiatry; Valproate sodium; Valproic acid

Indexed keywords

VALPROATE SEMISODIUM; VALPROIC ACID;

ACCURACY; ADULT; AGED; ARTICLE; BAYES THEOREM; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HYPOMANIA; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOPHRENIA;

ADAPTATION, PHYSIOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MIDDLE AGED; POPULATION SURVEILLANCE; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; VALPROIC ACID;

EID: 0032967540     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199906000-00019     Document Type: Article

References (16)

1. Nitsche V, Mascher H. The pharmacokinetics of valproic acid after oral and parenteral administration in healthy volunteers. Epilepsia 1982;23:153-62.
2. Pope, Jr. HG, McElroy SL, Keck, Jr. PE, Hudson JI. Valproate in the treatment of acute mania. Arch Gen Psychiatry 1991;48:62-8.
3. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-11.
4. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990;147:431-4.
5. Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992;12(suppl 1):53-6.
6. Schaff MR, Fawcett J, Zajecka JM. Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry 1993; 54:380-4.
7. Bowden CL, Janicak PG, Orsulak P, et al. Relation of serum valproate concentration to responses in mania. Am J Psychiatry 1996; 153:765-70.
8. Perucca E, Gatti G, Frigo GM, Crema A. Pharmacokinetics of valproic acid after oral and intravenous administration. Br J Clin Pharmac 1978;5:313-8.
9. Loiseau P, Brachet A, Henry P. Concentration of dipropylacetate in plasma. Epilepsia 1975;16:609-15.
10. Bruni J, Wilder BJ, Willmore LJ, Perchalski RJ, Villarreal HJ. Steady-state kinetics of valproic acid in epileptic patients. Clin Pharmacol Ther 1978;24:324-32.
11. Miljkovic B, Pokrajac M, Varagic V, Levic Z. Single dose and steady state pharmacokinetics of valproic acid in adult epileptic patients. Int J Clin Pharm Res 1991;11:137-41.
12. Hussein Z, Mukherjee D, Lamm J, Cavanaugh JH, Granneman GR. Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation. J Clin Pharmacol 1994;34:754-9.
13. Klotz U, Antonin KH. Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther 1977;21:736-43.
14. Jelliffe RW, Schumitzky A, Van Guilder M, et al. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, bayesian fitting, and adaptive control. Ther Drug Monit 1993;15:380-93.
15. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981;9:503-12.
16. Kuranari M, Chiba S, Ashikari Y, Kodama Y, Sakata T, Takeyama M. Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient. J Clin Pharm Ther 1996;21:83-7.